Cargando…

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A

Natural killer (NK) cells are attractive candidates for allogeneic cell-based immunotherapy due to their potent antitumor effector function and good safety profile. NK cells express killer immunoglobulin-like receptors (KIRs) and the NKG2A receptor important for NK cells education as well as providi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahaweni, Niken M., Ehlers, Femke A. I., Bos, Gerard M. J., Wieten, Lotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288976/ https://www.ncbi.nlm.nih.gov/pubmed/30564241 http://dx.doi.org/10.3389/fimmu.2018.02848

Ejemplares similares

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages
por: Ehlers, Femke A. I., et al.
Publicado: (2023)

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
por: Beelen, Nicky A., et al.
Publicado: (2022)

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
por: Sarkar, Subhashis, et al.
Publicado: (2015)

Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
por: Van Elssen, Catharina, et al.
Publicado: (2020)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
por: Leivas, Alejandra, et al.
Publicado: (2021)

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Modulation of NKG2D, KIR2DL and Cytokine Production by Pleurotus ostreatus Glucan Enhances Natural Killer Cell Cytotoxicity Toward Cancer Cells
por: EL-Deeb, Nehal M., et al.
Publicado: (2019)

NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
por: Brooks, Andrew G., et al.
Publicado: (1997)

Deciphering the biology of NKG2C+ natural killer cells
por: Rölle, Alexander
Publicado: (2015)

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
por: van Gelder, Michel, et al.
Publicado: (2016)

Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids
por: Beelen, Nicky A., et al.
Publicado: (2023)

Interaction of a dengue virus NS1‐derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells
por: Townsley, E., et al.
Publicado: (2015)

P1368: NKG2A DELETION IN HUMAN NATURAL KILLER CELLS ENHANCES ANTI-TUMOR RESPONSES AND PROMOTES TUMOR INFILTRATION
por: Gong, Ying, et al.
Publicado: (2023)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
por: David, Christina, et al.
Publicado: (2023)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
por: Della Chiesa, Mariella, et al.
Publicado: (2015)

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation(⋆)
por: Farhadi, Nazanin, et al.
Publicado: (2014)

Polymorphic differences within HLA‐C alleles contribute to alternatively spliced transcripts lacking exon 5
por: Ehlers, Femke A. I., et al.
Publicado: (2022)

Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
por: Petillo, Sara, et al.
Publicado: (2021)

Structure of Human Histocompatibility Leukocyte Antigen (Hla)-Cw4, a Ligand for the Kir2d Natural Killer Cell Inhibitory Receptor
por: Fan, Qing R., et al.
Publicado: (1999)

Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis
por: Cauli, Alberto, et al.
Publicado: (2018)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

Self-Association of an Activating Natural Killer Cell Receptor, KIR2DS1
por: Hayley, Michael, et al.
Publicado: (2011)

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
por: Sayitoglu, Ece Canan, et al.
Publicado: (2020)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques
por: Ries, Moritz, et al.
Publicado: (2017)

Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
por: Carapito, Raphael, et al.
Publicado: (2017)

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients
por: Pascual-Guardia, Sergi, et al.
Publicado: (2020)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
por: Siemaszko, Jagoda, et al.
Publicado: (2021)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
por: Yawata, Makoto, et al.
Publicado: (2006)

DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells
por: Chan, Huei-Wei, et al.
Publicado: (2003)

P851: ANTIBODY TARGETING OF SOLUBLE MHC-CLASS-I-RELATED MOLECULE AUGMENTS NATURAL KILLER CELL FUNCTION BY RESTORING NKG2D IN MULTIPLE MYELOMA
por: Kim, Sojeong, et al.
Publicado: (2023)

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
por: Zuo, Wei, et al.
Publicado: (2022)

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
por: Sarkar, Subhashis, et al.
Publicado: (2013)

Natural killer cell profiles in recurrent pregnancy loss: Increased expression and positive associations with TACTILE and LILRB1
por: Habets, Denise H. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nspc9gvd1ve27jmqhl1ijr5oje